RBR-48rxwb招募中4 期
Evaluation of the efficacy of SGLT2 inhibitor for Non-alcoholic Fatty Liver Disease in diabetics and non-diabetics: clinical trial
Centro Educacional Hyarte0 个研究点开始时间: 2020年1月2日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 20Y 至 75Y（—）
入选标准
- •Patients older than 20 years who present alterations in transaminases with cutoff above 35 U / l and hepatic fat content above 7.5% by MRI will be included.
- •Diabetic patients will include those with a disease duration of more than 6 months (under treatment) and less than 10 years; without the use of insulin therapy and using at maximum two oral antihyperglycaemic agents
排除标准
- •The exclusion criteria will be: alcohol use more than 30 grams / day over 10 years for men and more than 20 grams / day for women; viral hepatitis B and C and HIV; drugs that impair beta oxidation (methotrexate, amiodarone, tetracycline, tamoxifen, chemotherapeutics); autoimmune hepatitis; biliary diseases; metabolic genetic disorders; ferritin above 1000 mg / dL; recurrent urinary tract infection; diabetics using GLP-1 analogs or in oral double therapy.
研究者
相似试验
已完成
不适用
The efficacy and safety of SGLT2 inhibitor for non alcholic fatty liver disease in Japanese patients with type 2 diabetesJPRN-UMIN000016306Tokyo Medical and Dental University50
尚未招募
Unknown
Influence of SGLT2 inhibitors on the efficiency of peritoneal dialysisChronic kidney disease under peritoneal dialysisJPRN-UMIN000049848International University of Health and Welfare10
招募中
不适用
Efficacy and Safety of SGLT2 inhibitors in patients with type 1 diabete.type 1 diabetesJPRN-UMIN000044317Hokkaido University Hospital200
已完成
不适用
The efficacy of the administration of SGLT-2 inhibitor and/or DPP-4 inhibitor in type 2 diabetic patient with basal-bolus insulin therapy.JPRN-UMIN000020742Division of Endocrinology, Department of Medicine, Chiba-Hokusoh Hospital, Nippon Medical School60
已完成
不适用
The inhibitory effects of the SGLT2 inhibitor for progression of diabetic nephropathy, in the patients with type 2 diabetes in Japan.diabetic nephropathy in type 2 diabetes mellitusJPRN-UMIN000016754Saitama Medical Center, Saitama Medical University50